GOALS & OBJECTIVES
Early Treatment of Anemia: Improving Therapeutic Effectiveness for the Cancer Patient
Paper Symposium
Activity Date: May 2007  — Activity Info: Volume4, (5)
Goals & Objectives | Faculty | Introduction | Full Activity Content | CME Test & Evaluation (CME Expired)

 
GOAL
To provide pharmacists with up-to-date information regarding their role in the treatment of patients with chemotherapy-induced anemia (CIA).

TARGET AUDIENCE
This activity is designed for managed care and hospital pharmacists. No prerequisites required.

LEARNING OBJECTIVES
The University of Tennessee College of Pharmacy takes responsibility for the content, quality, and scientific integrity of this CE activity. At the conclusion of this activity, the participant should be able to:
  • Demonstrate the importance of early intervention in the management of CIA.
  • Recognize the ramifications of CIA and its impact on patient outcomes and quality of life.
  • Describe and implement the use of available therapeutic options for CIA, with special focus on dosing schedules and regimens.
  • Integrate evidence-based medicine for anemia management into a total patient care plan to optimize outcomes.
  • Summarize the role of the pharmacist in the treatment and management of CIA.
  • Identify the pharmacoeconomic issues and overcome the reimbursement challenges associated with treating CIA.
  • Explain the proper use of treatments and the safety measures for adverse events.
ACCREDITATION STATEMENT
The University of Tennessee College of Pharmacy (UTCOP) is accredited by the Accreditation Council for Pharmacy Education (ACPE) to provide continuing education for pharmacists.

CREDIT DESIGNATION STATEMENT
This program is approved for 2 hours of credit (0.2 CEUs) and is sponsored by the University of Tennessee College of Pharmacy, which is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE Program # 064-000-07-207-H01

This continuing education activity was produced under the supervision of Glen E. Farr, PharmD, Associate Dean for Continuing Pharmacy Education, University of Tennessee College of Pharmacy.

The estimated time to complete this educational activity:  2 hours.

Release date: May 15, 2007. Expiration date: May 15, 2009.

DISCLAIMER STATEMENT
The opinions and recommendations expressed by faculty and other experts whose input is included in this program are their own. This enduring material is produced for educational purposes only. Use of University of Tennessee College of Pharmacy name implies review of educational format, design, and approach. Please review the complete prescribing information of specific drugs or combinations of drugs, including indications, contraindications, warnings, and adverse effects, before administering pharmacologic therapy to patients.

GRIEVANCE POLICY
A participant, sponsor, faculty member, or other individual wanting to file a grievance with respect to any aspect of a program sponsored or co-sponsored by the UTCOP may contact the Associate Dean for Continuing Education in writing. The grievance will be reviewed and a response will be returned within 45 days of receiving the written statement. If not satisfied, an appeal to the Dean of the College of Pharmacy can be made for a second level of review.

This program is supported by an educational grant from Ortho Biotech, Inc.
     
Home | Contact Us | View Account | Need Help?